Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by NightHawk1987on May 16, 2020 2:59pm
232 Views
Post# 31038255

Finding Ifenprodyl on super computer

Finding Ifenprodyl on super computerIn the video that mark put on... the science of Ifenprodyl I think its called. At about minute 14 or 15 he talks about 2 drugs that the super computer found as potential treatments for covid. (Please correct me if I'm wrong, full disclosure I haven't had time for the full video) I believe Ifenprodyl was drug #42 and the other was #67. Does anybody know what/who has #67, and if they are exploring it? I ask because it is a potential competitor. Also, same thing with Merke and Bellus. Does anybody know if their drugs for chronic cough has been explored for covid? I'm just guessing, but I would think they all have similar compounds in the drugs since they are treating the same thing. For me, it's important to know our competitors just as well as our company. Any logical, respectful and thoughtful insight in welcome. This board is for information and sharing insight. Please keep the bickering off.
<< Previous
Bullboard Posts
Next >>